Employement of supplement bioestimulin in oncohematologic patients

Abstract

To evaluate the effectiveness and the acceptance of nutritional supplement Bioestimulin in oncohematologics patients, two groups were studied; a first group of the oncology consultation and a second group of the hematology consultation, for a total of 92 patients. 15 g of Bioestimulin three times at days (45 g/d) were given to each patient of both groups. Hemoglobin analysis was carried out to all patients at the beginning of the study and the three months after the supplement administration to establish the comparison with the values of this complementary analysis. Also, seric iron evaluation in patients of hematology consultation was done. The acceptance of product was determinate using an interview in all patients. The treatment with 45 g/d of Bioestimulin supplement increased significantly the hemoglobin to the 90 days in all oncohematologic patients. The seric iron also increased significantly in the patients of the hematology consultation. This product was accepted by all patients. The treatment with the nutritional supplement Bioestimulin is effective for the prevention and control of the anaemia in oncohematologic patient.